Scholarlink

<p>Pancreatic ductal adenocarcinoma (PDA) remains largely refractory to anti-angiogenic strategies, and non-endothelial perfusion mechanisms such as vasculogenic mimicry (VM, endothelial-like channels formed by tumour cells) may sustain tumour progression. Here, we examined whether the combined knockout of p21-activated kinase 1 and 4 (PAK1&amp;4) affects vascular mimicry (VM) programmes in pancreatic cancer. KPC wild-type or PAK1&amp;4 knockout cells were injected subcutaneously into immunodeficient mice. Knockout of PAK1&amp; 4 suppressed tumour growth, associated with VM inhibition, but not endothelial angiogenesis. Knockout of PAK1&amp; 4 reduced tumour expression of VM markers EphA2, VE-cadherin and MCAM, and decreased EphA2⁺VE-cadherin⁺ and EphA2⁺MCAM⁺, CD31<sup>+</sup>VE-cadherin<sup>+</sup> and CD31<sup>+</sup>MCAM<sup>+</sup> cells. In vitro, PAK1 knockout and PAK1&amp; 4 knockout suppressed VM-like tube formation and migration, whereas PAK4 knockout enhanced tube formation. Global proteomics linked PAK1 knockout to downregulation of EPH–Ephrin signalling and reduced EphA2–MCAM–RhoA abundance, while PAK4 knockout enriched blood-vessel morphogenesis molecules. These findings identify a PAK-dependent VM programme and suggest that dual PAK targeting inhibits tumour growth by VM inhibition.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Knockout of PAK1 and PAK4 supresses tumour growth associated with vasculogenic mimicry inhibition through EphA2–VE-cadherin–MCAM pathway

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年3月13日

查看全文
  • Arian Ansardamavandi,
  • Chelsea Dumesny,
  • Sarah Ellis,
  • Ching-Seng Ang,
  • Mehrdad Nikfarjam,
  • Hong He

摘要

Pancreatic ductal adenocarcinoma (PDA) remains largely refractory to anti-angiogenic strategies, and non-endothelial perfusion mechanisms such as vasculogenic mimicry (VM, endothelial-like channels formed by tumour cells) may sustain tumour progression. Here, we examined whether the combined knockout of p21-activated kinase 1 and 4 (PAK1&4) affects vascular mimicry (VM) programmes in pancreatic cancer. KPC wild-type or PAK1&4 knockout cells were injected subcutaneously into immunodeficient mice. Knockout of PAK1& 4 suppressed tumour growth, associated with VM inhibition, but not endothelial angiogenesis. Knockout of PAK1& 4 reduced tumour expression of VM markers EphA2, VE-cadherin and MCAM, and decreased EphA2⁺VE-cadherin⁺ and EphA2⁺MCAM⁺, CD31+VE-cadherin+ and CD31+MCAM+ cells. In vitro, PAK1 knockout and PAK1& 4 knockout suppressed VM-like tube formation and migration, whereas PAK4 knockout enhanced tube formation. Global proteomics linked PAK1 knockout to downregulation of EPH–Ephrin signalling and reduced EphA2–MCAM–RhoA abundance, while PAK4 knockout enriched blood-vessel morphogenesis molecules. These findings identify a PAK-dependent VM programme and suggest that dual PAK targeting inhibits tumour growth by VM inhibition.